A Clinical Investigation of the Taperloc® Microplasty™ Hip System
Completed
Conditions studied: Osteoarthritis, Rheumatoid Arthritis, Avascular Necrosis
In brief
The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Taperloc® Microplasty™ Hip System.
Key facts
- Study ID
- NCT00699309
- Run by
- Biomet Orthopedics, LLC
- People needed
- 98
- Starts
- 2005-08-01
- Expected to finish
- 2013-03-01
- Last updated by the study team
- 2017-06-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis
- Rheumatoid arthritis.
- Correction of functional deformity.
- Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques.
- Revision of previously failed femoral head resurfacing component
You may not qualify if…
- Absolute contraindications include:
- infection,
- sepsis, and
- osteomyelitis.
- Relative contraindications include:
- uncooperative patient or patient with neurologic disorders who are incapable of following directions,
- osteoporosis,
- metabolic disorders which may impair bone formation,
- osteomalacia,
- distant foci of infections which may spread to the implant site,
- rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram,
- vascular insufficiency, muscular atrophy, or neuromuscular disease.
Where it is running
- Low Country Bone & Joint Specialists — Beaufort, South Carolina, United States
- Piedmont Orthopedics — Greenville, South Carolina, United States
- Texas Center for Joint Replacement — Plano, Texas, United States
- Arthritis & Sports Orthopaedics — Sterling, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.